REFERENCES
- Metha S., Moore R.D., Graham N.M.H. Potential Factors Affecting Adherence with HIV Therapy. AIDS 1997; 11: 1665–1670
- Carpenter C.C.J., Fischl M.A., Hammer S.M. Antiretroviral Therapy for HIV Infection in 1998. JAMA 1998; 280: 78–86
- Williams A., Friedland G. Adherence,Compliance, and HAART. Aids Clinical Care 1997; 9: 51–55
- Buscema M. Introduction: Health and Life. Substance Use Misuse 1998; 33: 1–16
- Samet J.H., Libman H., Steger K.A. Compliance With Zidovudine Therapy in Patients Infected with Human Immunodeficiency Virus. Am. J. Med. 1992; 92: 495–502
- Eraker S.A., Kirscht J.P., Becker M.H. Understanding and Improving Patient Compliance. Ann. Intern. Med. 1984; 100: 258–268
- Paterson D., Swindells S., Mohr J. How Much Adherence is Enough?. 6th Conference on Retroviruses and Opportunistic Infections, Chicago, Jan. 31–Febr. 4, 1999
- Sherer R. Adherence and Antiretroviral Therapy in Injection Drug Users. JAMA 1998; 280: 567–568
- Strathdee S.A., Palepu A., Cornelisse P.G.A. Barriers to Use of Free Antiretroviral Therapy in Injection Drug Users. JAMA 1998; 280: 547–549
- Celentano D.D., Vlahov D., Cohn S. Self-reported Antiretroviral Therapy in Injection Drug Users. JAMA 1998; 280: 544–546
- Werf van de M.J., Schinkel J., Santen van G. HAART Among Drug Users in Amsterdam: Self-perceived Reasons for Not Receiving Therapy. AIDS 1999; 13: 1280–1281
- Gordillo V., Del Amo J., Soriano V. Sociodemographic and Psychological Variables Influencing Adherence to Antiretroviral Therapy. AIDS 1999; 13: 1763–1769
- Freeman R.C., Rodriquez G.M., French J.F. Compliance with AZT Treatment Regimen of HIV-Seropositive Injection Drug Users. Aids Educ. Prev. 1996; 8: 58–71
- Singh N., Squier C., Sivek C. Determinants of Compliance with Antiretroviral Therapy in Patients with Human Immunodeficiency Virus. AIDS Care 1996; 8: 261–269
- Eldred L.J., Wu A.W., Chaisson R.E. Adherence to Antiretroviral and Pneumocystis Prophylaxis in HIV Disease. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1998; 18: 117–125
- Muma R.D., Ross M.W., Parcel G.S. Zidovudine Adherence Among Individuals with HIV Infection. AIDS Care 1995; 7: 439–447
- Haastrecht van H. The Evolving HIV Epidemic, Mortality and Morbidity Among Drug Users in Amsterdam. Academisch Proefschrift [PhD thesis], faculteit der geneeskunde UVA 1995
- Nieuwkerk P.T., Sprangers M.A.G. Limited Patient Adherence to Highly Active Antiretroviral Therapy for HIV-1 Infection in an Observational Cohort Study. Arch. Intern. Med. 2001; 161: 1962–1968
- Glaser B.G., Strauss A.L. The Discovery of Grounded Theory. Aldine, Chicago 1967
- Hoetelmans R.M.W. Geneesmiddelinteracties Tussen Methadon en Antiretrovirale Medicatie (Drug Interactions Between Methadone and Antiretroviral Medication). T. Alc. Drugs 1998; 23: 97–104
- Bangsberg D., Tulsky J.P., Hecht F.M. Protease Inhibitors in the Homeless. JAMA 1997; 278: 63–65
- Grinspoon L., Bakalar J.B. Marijuana as Medicine, Plea for Reconsideration. JAMA 1995; 273: 1875–1876
- Grinspoon L., Bakalar J.B. Marijuana, he Aids Wasting Syndrome, and the U.S. Government. N. Engl. J. Med. 1995; 333: 670–671
- Hulka B.S., Cassel J.C., Kupper L.L. Communication, dherence/Compliance and Concordance Between Physicians and Patients with Prescribed Medications. Am. J. Pub. Health 1976; 66: 847–853
- Blackwell B. The Drug Regimen and Treatment Adherence. Adherence in Health Care. Johns Hopkins University Press, Baltimore 1997
- Besch C.L. Compliance in Clinical Trials. AIDS 1995; 9: 1–10
- Ferrando S.J., Wall T.L., Batki S.L. Psychiatric Morbidity, llicit Drug Use and Adherence to Zidovudine Among Injection Drug Users with HIV Disease. Am. J. Drug Alcohol Abuse 1996; 22: 475–487
- O’Conner P.G., Selwyn P.A., Schottenfeld R.S. Medical Care for Injection-drug Users with HIV. N. Engl. J. Med. 1994; 331: 450–459
- Haynes R.B., Taylor D.W., Sackett D.L. Adherence in Health Care. Johns Hopkins University Press, Baltimore 1979